The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats--a comparative study
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
14329
Cancer Research UK - United Kingdom
PubMed
24769487
DOI
10.1016/j.mrgentox.2014.01.012
PII: S1383-5718(14)00104-1
Knihovny.cz E-zdroje
- Klíčová slova
- Aristolochic acid nephropathy, DNA adducts, Metabolic activation, NAD(P):quinone oxidoreductase, Protein expression,
- MeSH
- aktivace enzymů účinky léků MeSH
- cytosol enzymologie MeSH
- játra enzymologie patologie MeSH
- karcinogeny farmakologie MeSH
- krysa rodu Rattus MeSH
- kyseliny aristolochové farmakologie MeSH
- ledviny enzymologie patologie MeSH
- myši knockoutované MeSH
- myši MeSH
- NAD(P)H dehydrogenasa (chinon) metabolismus MeSH
- plíce enzymologie patologie MeSH
- potkani Wistar MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- aristolochic acid I MeSH Prohlížeč
- karcinogeny MeSH
- kyseliny aristolochové MeSH
- NAD(P)H dehydrogenasa (chinon) MeSH
- Nqo1 protein, mouse MeSH Prohlížeč
- NQO1 protein, rat MeSH Prohlížeč
UNLABELLED: Aristolochic acid is the cause of aristolochic acid nephropathy (AAN) and Balkan endemic nephropathy (BEN) and their associated urothelial malignancies. Using Western blotting, we investigated the expression of NAD(P)H: quinone oxidoreductase (NQO1), the most efficient cytosolic enzyme that reductively activates aristolochic acid I (AAI) in mice and rats. In addition, the effect of AAI on the expression of the NQO1 protein and its enzymatic activity in these experimental animal models was examined. We found that NQO1 protein levels in cytosolic fractions isolated from liver, kidney and lung of mice differed from those expressed in these organs of rats. In mice, the highest levels of NQO1 protein and NQO1 activity were found in the kidney, followed by lung and liver. In contrast, the NQO1 protein levels and enzyme activity were lowest in rat-kidney cytosol, whereas the highest amounts of NQO1 protein and activity were found in lung cytosols, followed by those of liver. NQO1 protein and enzyme activity were induced in liver and kidney of AAI-pretreated mice compared with those of untreated mice. NQO1 protein and enzyme activity were also induced in rat kidney by AAI. Furthermore, the increase in hepatic and renal NQO1 enzyme activity was associated with AAI bio-activation and elevated AAI-DNA adduct levels were found in ex vivo incubations of cytosolic fractions with DNA and AAI. In conclusion, our results indicate that AAI can increase its own metabolic activation by inducing NQO1, thereby enhancing its own genotoxic potential.
Citace poskytuje Crossref.org
The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
Balkan endemic nephropathy: an update on its aetiology